#SLE/ Lupus treatment in Pune

[dr-nilesh-patil]

[drsaurabhgiri]

Dr. Saurabh Giri: Your Trusted Orthopedic Surgeon for Joint Pain Treatment in Pune

Joint pain can significantly affect our daily lives, hindering our mobility and causing discomfort. If you’re experiencing joint pain, it’s essential to seek proper medical attention to diagnose and treat the underlying cause. In Pune, one name stands out in the field of orthopedics—Dr. Saurabh Giri. With his expertise and commitment to patient care, Dr. Giri has become a trusted orthopedic surgeon 

specializing in joint pain treatment in the PCMC region.

Understanding Joint Pain:

Joint pain refers to discomfort, soreness, or inflammation in the joints—the points where two bones meet. It can affect any part of the body, including the knees, hips, shoulders, and wrists. Joint pain can vary in severity, from mild to debilitating, and can be caused by various factors.

Causes of Joint Pain:

Arthritis: Osteoarthritis, rheumatoid arthritis, and gout are common types of arthritis that can cause joint pain. These conditions lead to inflammation, cartilage damage, and joint stiffness.

Injuries: Accidents, sports-related injuries, or repetitive motions can lead to joint pain. Sprains, strains, and fractures can cause immediate discomfort and long-term joint issues.

Overuse and Age: Overuse of joints due to repetitive activities, coupled with the natural wear and tear associated with aging, can result in joint pain.

Infections: Certain infections, such as Lyme disease, influenza, or viral hepatitis, can cause joint pain as a symptom.

Other Factors: Conditions like bursitis, tendinitis, fibromyalgia, and systemic lupus erythematosus (SLE) can also contribute to joint pain. Surgical Alternatives for Joint Pain:

When conservative treatments such as medication, physical therapy, and lifestyle modifications fail to alleviate joint pain, surgical intervention may be necessary. Dr. Saurabh Giri offers a range of surgical alternatives to address joint pain, including:

Joint Replacement Surgery: This procedure involves replacing damaged joints with artificial implants to restore function and reduce pain.

Arthroscopy: It is a minimally invasive surgical technique that uses a small camera to visualize, diagnose, and treat joint problems.

Joint Fusion: In cases where joint replacement is not feasible, joint fusion surgery may be recommended to fuse the bones in the joint, eliminating the painful motion.

Cost of Joint Pain Treatment in Pune:

The cost of joint pain treatment can vary based on various factors, including the type of surgery required, the complexity of the case, hospital charges, and post-operative care. It is advisable to consult with Dr. Saurabh Giri to get a personalized assessment and accurate cost estimation for your specific condition.

Why Choose Dr. Saurabh Giri for Joint Pain Treatment in Pune?

Expertise and Experience: Dr. Saurabh Giri is a highly skilled orthopedic surgeon with extensive experience in treating joint pain conditions. He stays updated with the latest advancements in the field to provide the best possible care to his patients.

Patient-Centric Approach: Dr. Giri believes in a patient-centric approach, where he takes the time to understand each patient’s unique concerns and develops a personalized treatment plan accordingly. He values effective communication and ensures that his patients are well-informed and comfortable throughout the treatment process.

[rdagade]

Global Lupus Market

Global Lupus Market size was valued US$ 1.67 Bn. in 2019 and the total revenue is expected to grow at 12.41% from 2019 to 2027, reaching nearly US$ XX Bn.

Global Lupus Market

To know about the Research Methodology :- Request Free Sample Report

The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.

Lupus is a chronic autoimmune disease that causes inflammation all over the body. In patients with lupus, the immune system attacks its own tissues and can damage several parts of the body including kidney, heart, skin, joints, lungs, brain, and blood vessels. Lupus patients may be at higher risk of developing severe infections if they develop COVID-19.

The market for lupus is expanding at breakneck speed across the world because of the surging prevalence of lupus and the ongoing medical developments in treating systemic lupus erythematosus. The increased R&D activities for lupus can be considered a driving factor. Throughout the world, approximately 5 million people suffer from lupus and 70% of the total cases are systemic lupus erythematosus. As per the Lupus Foundation of America, approximately 1.5 million Americans have a form of lupus, and around 16,000 new cases are reported yearly in the Americans. However, stringent regulatory guidelines for new drugs and the cost restraint are expected to be among the primary hindrance. Likewise, the MMR report covers all the trends and technologies playing a major role in the growth of the lupus market over the 2019-2027. It highlights the drivers, restraints, and opportunities expected to influence the lupus market growth during the forecast period.

North America’s lupus market was valued at US$ XX.12 Mn. in 2019 and is expected to reach a value of US$ XX.89 Mn. by 2027, with a CAGR of XX.50% during the forecast period. This is owing to the availability of reimbursement, growing demand for better treatment options, rising prevalence of lupus, government initiatives for lupus. Moreover, the developed healthcare infrastructure and accessibility to biologics are likely to contribute to the lupus market growth in the region.

The U.S. has the highest number of people diagnosed from LN in 2017, followed by the U.K. and Japan. The prevalence of lupus nephritis in the AAPC SLE patient population is much higher than in Caucasians. Therefore, it represents a large and well-defined market opportunity with very little competition and is expected to be worth US$ XX.89 billion by 2019 at a CAGR of XX.29 %.

The report covers the segments in the lupus market such as application, technique, and product. By product, the immunosuppressant segment is expected to continue to hold the largest XX.85% share in the lupus market because of its low cost and high accessibility. However, the biologics segment holds the second-largest share in the lupus market and it is expected to grow at a CAGR of XX.15 % during the forecast period. The introduction of new biologics with improved efficacy is probable to support the growth of the global market.

In recent years, major companies in the lupus market have taken several strategic measures, such as facility expansions and partnerships. In July 2017, GlaxoSmithKline Company received approval from the FDA for developing a novel self-injectable formulation of Benlysta which can treat systemic lupus erythematosus in adults. The use of Benlysta has exposed a decrease and improvements in the ingesting of anti-inflammatory glucocorticoids.

The GlaxoSmithKline Company is further conducting advanced product development, clinical trials, and combination therapy studies with rituximab to upsurge the opportunities for the therapy. The advent of numerous new biological or natural treatments is adding to the treatment options and drug costs, so inflating the growth of the lupus market.

The objective of the report is to present a comprehensive analysis of the Global Lupus Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Lupus Market dynamics, structure by analyzing the market segments and projects the Global Lupus Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Lupus Market make the report investor’s guide.

For more information visit@ https://www.maximizemarketresearch.com/market-report/global-lupus-market/65753/

Scope of the Global Lupus Market: Inquire before buying

Global Lupus Market, by Technique

• Systemic Lupus Erythematosus • Cutaneous Lupus Erythematosus • Drug-Induced Lupus Erythematosus • Neonatal Lupus Global Lupus Market, by Product

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) • Antimalarial Drugs • Corticosteroids • Immunosuppressants • Biologics • Others Global Lupus Market, by End User

• Hospital & Clinics • Diagnostic Laboratories • Others Global Lupus Market, by Region

• Asia Pacific • North America • Europe • South America • Middle East & Africa Key players operating in the Global Lupus Market

• Aurinia Pharmaceuticals, Inc. • Bristol-Myers Squibb Company • Cadila Healthcare • GlaxoSmithKline plc • Mylan N.V. • F. Hoffmann-La Roche AG • Pfizer, Inc. • Sanofi • Lycera Corporation • Merck KGaA • Eli Lily and Company

This report submitted by Maximize market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact: +919607195908

[rhematologistclinicpune]

Meet the best Rheumatologist in Pune? Dr.Nilesh Patil is a well known Specialist Doctor for Rheumatologist.He provides the Lupus/sle Treatment in Pune.

[rohit09exactitudeconsultancy]

Autoimmune Disease Diagnostics Market scarcity of technicians, and price war between companies are likely to hinder market growth during the forecast period

Autoimmune Disease Diagnostics Market

Autoimmune disease is a disorder where body’s own immune system starts attacking the healthy cells instead of foreign particles and disease-causing agents. The rising awareness about autoimmune disorders, technological advancement in the healthcare sector and rise in number of cases of autoimmune diseases are the factors driving the growth of the global autoimmune disease diagnostics market.

The rising cases of false positive result of autoimmune disorders, scarcity of technicians, and price war between companies are likely to hinder market growth during the forecast period.

Get More details on https://www.wrcbtv.com/story/39729250/report-2019-autoimmune-disease-diagnostics-market-clinical-technique-significance-treatment-and-management-research-by-symptoms-risk-factors

Segmentation:

The global autoimmune disease diagnostics market has been segmented on the basis of disease type, test type, and end-user.

The market, by disease type, has been classified as systemic autoimmune disease, and localized autoimmune disease. The systemic autoimmune disease segment has been further classified into psoriasis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus (SLE), and others. Localized autoimmune disease segment has been divided into inflammatory bowel disease, thyroid, type 1 diabetes, and others.

On the basis of test type, the market has been segregated into  western blotting, enzyme-linked immunosorbent assay (ELISA), double immune diffusion, dot blot, counter immune-electrophoresis, line blot, immunofluorescence assays (IFA), multiplex immunoassay, agglutination, and others.

The end-user segment has been divided into, has been segmented into hospitals, diagnostics centers, research laboratories, and others

More reference:

https://www.medgadget.com/2019/03/autoimmune-disease-diagnostics-market-2019-expected-to-register-7-6-cagr-by-disease-type-diagnosis-and-management-forecast-2023.html

http://www.technologiesclusters.com/feed-items/autoimmune-disease-diagnostics-market-share-accounted-to-register-at-7-6-cagr-till-2023-by-type

https://www.medgadget.com/2019/04/autoimmune-disease-diagnostics-market-research-by-treatment-procedures-test-type-symptoms-and-industry-outlook-2023.html

Key Players:

Some of the key players in the global autoimmune disease diagnostics market are Siemens Healthcare Private Limited, bioMérieux SA, Bio-rad Laboratories, Beckman Coulter, Inc., AstraZeneca, EUROIMMUN AG, F. Hoffmann-la Roche, Inova Diagnostics, Inc.,Myriad Genetics, Inc., Thermo Fisher Scientific, Trinity Biotech Plc., and Hemagen Diagnostics, Inc.

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

[isiawgr-blog]

Anti-nuclear Antibody (ANA) Testing Market-Outlook, Regulatory Bodies, Trends, Industry Insights & Forecast

Market Scenario:

Anti-nuclear Antibody (ANA) Test is used to detect antinuclear antibodies in blood. Immune system makes antibodies to fight with various infections. Antinuclear antibodies often attack on own tissues. ANA test helps to determine autoimmune diseases like rheumatoid arthritis and lupus. Increasing technological advancements, adoption of new techniques and increasing prevalence of various autoimmune diseases are driving the growth for global anti-nuclear antibody (ANA) testing market. Major brands are investing money in R&D to develop more advanced product for the market that is another key driver for the market.

The Global Anti-Nuclear Antibody (ANA) Testing Market is growing at the CAGR of ~9.6% during the forecast period and expected to reach US$ 1300.6 million by 2023.

Segments:                                                                                                            Global Anti-nuclear Antibody (ANA) Testing Market has been segmented on the basis of type which comprise immunofluorescence (Primary or direct and Secondary or indirect), enzymelinked, immunosorbent assay (ELISA) (Direct ELISA, Indirect ELISA, Sandwich ELISA, Competition/Inhibition ELISA), and others. On the basis of application, it segmented into Rheumatoid arthritis (Seropositive, Seronegative), Systemic lupus erythematosus (SLE) (Discoid lupus erythematosus, Subacute cutaneous lupus erythematosus, Neonatal lupus), Polymyositis, Scleroderma (localized scleroderma, systemic scleroderma), Sjögren's syndrome (Primary, secondary), and others. On the basis of end user, it segmented into Hospitals and clinics, research laboratories, and others.

Regional Analysis of Global Anti-nuclear Antibody (ANA) Testing Market:    Considering the global scenario of the market, North America is largest market for Anti-nuclear Antibody (ANA) Testing, in North America region US hold largest market share while European market is second largest, and especially the growth rate is higher in west European countries. On the other hand, Asia-Pacific (APAC) is fastest growing market and expected to grow significantly during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of devices and treatment. 

Get Sample copy at https://www.marketresearchfuture.com/sample_request/3210 .

Key Players for Global Anti-nuclear Antibody (ANA) Testing Market:     

Some of the key players in this market are: Abcam plc. (US), Alere (US), Antibodies Inc.(US), Bio-Rad Laboratories, Inc. (US), Erba Diagnostics (US), Indur Services, Inc. (US), MBL INTERNATIONAL (US), Merck KGaA (Germany), Trinity Biotech (Republic of Ireland)

Table of Contents

1    Introduction

     1.1   Definition

     1.2   Scope of Study

     1.3   Research Objective

     1.4   Assumptions & Limitations

     1.5   Market Structure:

2    Research Methodology

     2.1   Research Process

     2.2   Primary Research

     2.3   Secondary Research

3    Market Dynamics

     3.1   Drivers

     3.2   Restraints

     3.3   Opportunities

     3.4   Challenges

     3.5   Macroeconomic Indicators

4    Market Factor Analysis

Cont…

Get Discounted report https://www.marketresearchfuture.com/check-discount/3210 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India +1 646 845 9312 Email: salesteam@marketresearchfuture.com

[dr-nilesh-patil]

Lupus: Its Symptoms, Treatment & Testing

Introduction to Lupus

 Lupus, also known as systemic lupus erythematosus (SLE), is a chronic autoimmune disease that affects various parts of the body. It occurs when the immune system mistakenly attacks healthy tissues, leading to inflammation and damage. Lupus can have a wide range of symptoms and can affect people of all ages, although it is more common in women of childbearing age. Dr. Nilesh Patil Provides Treatment of lupus in Pune he has huge experience in treating conditions like Rheumatoid arthritis, psoriatic arthritis, Gout, Osteoarthritis, Ankylosing spondylitis, fibromyalgia, and other complex inflammatory joint disorders as per the latest clinical guidelines and evidence-based medicine. she is the best for Lupus/SLE Treatment Pune.

Understanding the Symptoms of Lupus

Lupus is a complex disease with diverse symptoms that can vary from person to person. Some common symptoms of lupus include extreme fatigue, joint pain and swelling, skin rashes, fever, hair loss, and sensitivity to sunlight. Other symptoms may include chest pain, headaches, mouth ulcers, and swollen lymph nodes. It is important to note that the symptoms can flare up and subside periodically.

Different Types of Lupus

There are different types of lupus, including systemic lupus erythematosus (SLE), cutaneous lupus erythematosus (CLE), drug-induced lupus, and neonatal lupus. SLE is the most common and severe form of lupus, affecting multiple organs and systems in the body. CLE primarily affects the skin, causing rashes and lesions.

Diagnosing Lupus

Diagnosing lupus can be challenging as its symptoms can mimic other conditions. Medical professionals use a combination of clinical criteria, medical history, physical examination, and laboratory tests to diagnose lupus. Blood tests, such as antinuclear antibody (ANA) test, complete blood count (CBC), and erythrocyte sedimentation rate (ESR), can help in the diagnosis.

Treatment Options for Lupus

While there is no cure for lupus, various treatment options aim to control symptoms, prevent organ damage, and improve quality of life. The treatment plan is tailored to the individual's specific needs and may include medications, lifestyle changes, and alternative therapies.

Medications for Lupus Management

Medications play a crucial role in managing lupus symptoms and preventing flares. Nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, antimalarial drugs, and immunosuppressants are commonly prescribed to reduce inflammation, manage pain, and modulate the immune response.

Lifestyle Changes to Manage Lupus

In addition to medications, certain lifestyle changes can help individuals manage their lupus symptoms effectively. This includes getting regular exercise, maintaining a balanced diet, managing stress, avoiding triggers like sunlight exposure, and getting enough rest and sleep.

Alternative and Complementary Therapies

Many individuals with lupus explore alternative and complementary therapies to supplement their conventional treatment. These may include acupuncture, massage therapy, herbal supplements, and mind-body practices like yoga and meditation. It is important to consult with healthcare professionals before incorporating these therapies into the treatment plan.

Coping with Lupus: Emotional and Mental Well-being

Living with lupus can have a significant impact on a person's emotional and mental well-being. The chronic nature of the disease, along with its unpredictable symptoms and potential complications, can lead to feelings of anxiety, depression, and stress. Seeking support from loved ones, joining support groups, and engaging in therapy can be helpful in coping with the emotional challenges of lupus.

Pregnancy and Lupus

Pregnancy can present unique challenges for women with lupus. It is important for individuals with lupus to work closely with their healthcare team to plan for a healthy pregnancy. With proper management and monitoring, many women with lupus can have successful pregnancies and healthy babies.

Lupus in Children and Teens

Lupus can also affect children and teenagers, although it is relatively rare. Pediatric lupus often has similar symptoms to adult lupus, but it may also involve complications related to growth and development. Early diagnosis, appropriate treatment, and ongoing medical care are essential for managing lupus in children and teens.

Research and Advancements in Lupus Treatment

Ongoing research and advancements in lupus treatment have led to better understanding and improved management of the disease. Scientists are studying potential new medications, exploring the role of genetics, and investigating the underlying causes of lupus. Clinical trials provide opportunities for individuals with lupus to access experimental treatments and contribute to medical advancements.

Tips for Supporting a Loved One with Lupus

If someone you care about has lupus, there are several ways you can provide support. Educate yourself about the disease, be understanding and empathetic, offer assistance with daily tasks when needed, and encourage them to prioritize self-care. Regular communication and validation of their experiences can go a long way in providing emotional support.

Conclusion

Lupus is a complex autoimmune disease that affects multiple organs and systems in the body. With proper management and care, individuals with lupus can lead fulfilling lives. It is essential to work closely with healthcare professionals, follow the prescribed treatment plan, make necessary lifestyle changes, and seek emotional support when nee